AR, G., V, M., X, Z., CR, C., MD, W., KM, R., . . . JW, G. (2024). Nucleocapsid protein-specific monoclonal antibodies protect mice against Crimean-Congo hemorrhagic fever virus. Nature communications, 15(1), 1722. https://doi.org/10.1038/s41467-024-46110-4
Chicago Style (17th ed.) CitationAR, Garrison, et al. "Nucleocapsid Protein-specific Monoclonal Antibodies Protect Mice Against Crimean-Congo Hemorrhagic Fever Virus." Nature Communications 15, no. 1 (2024): 1722. https://doi.org/10.1038/s41467-024-46110-4.
MLA (9th ed.) CitationAR, Garrison, et al. "Nucleocapsid Protein-specific Monoclonal Antibodies Protect Mice Against Crimean-Congo Hemorrhagic Fever Virus." Nature Communications, vol. 15, no. 1, 2024, p. 1722, https://doi.org/10.1038/s41467-024-46110-4.